Ruoh-Fang Yen1, Yee-Chun Chen, Yen-Wen Wu, Mei-Hsiu Pan, Shan-Chwen Chang. 1. Department of Nuclear Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan. rfyen@ha.mc.ntu.edu.tw
Abstract
RATIONALE AND OBJECTIVES: We evaluated the effectiveness of positron emission tomography (PET) with 18-fluoro-2-deoxyglucose (FDG) in the detection of infectious endocarditis/endoarteritis. MATERIALS AND METHODS: For this study, we recruited 6 patients (4 women, 2 men; age range, 35 - 78 years; mean age, 55.8 +/- 16.8 years) who were clinically diagnosed as having infective endocarditis/endoarteritis by their echocardiographic findings and by Duke criteria. RESULTS: For all 6 patients, we also found increased FDG uptakes in the corresponding areas detected in echocardiography. CONCLUSION: FDG-PET appears to be a promising tool in diagnosing infective endocarditis/endoarteritis, and further prospective studies on a large scale to fully exploit the usefulness of FDG-PET for infective endocarditis/endoarteritis are needed.
RATIONALE AND OBJECTIVES: We evaluated the effectiveness of positron emission tomography (PET) with 18-fluoro-2-deoxyglucose (FDG) in the detection of infectious endocarditis/endoarteritis. MATERIALS AND METHODS: For this study, we recruited 6 patients (4 women, 2 men; age range, 35 - 78 years; mean age, 55.8 +/- 16.8 years) who were clinically diagnosed as having infective endocarditis/endoarteritis by their echocardiographic findings and by Duke criteria. RESULTS: For all 6 patients, we also found increased FDG uptakes in the corresponding areas detected in echocardiography. CONCLUSION:FDG-PET appears to be a promising tool in diagnosing infective endocarditis/endoarteritis, and further prospective studies on a large scale to fully exploit the usefulness of FDG-PET for infective endocarditis/endoarteritis are needed.
Authors: Laura R A Schouten; Hein J Verberne; Berto J Bouma; Berthe L F van Eck-Smit; Barbara J M Mulder Journal: J Nucl Cardiol Date: 2007-12-26 Impact factor: 5.952